Review
Copyright ©The Author(s) 2017.
World J Immunol. Jul 27, 2017; 7(2): 11-23
Published online Jul 27, 2017. doi: 10.5411/wji.v7.i2.11
Table 2 Summary of inflammation and cancer relationship
Basic observationsInterpretation
Chronic inflammation increases cancer riskCausality is not proven[47]
Inflammation from psoriasis actually reduces cancer risk
AIs decrease cancerAIs are proven to decrease cancer risk as shown in Coley’s toxin[93]
AIs may mobilize strong immune responses and create cancer resisting environment[94,95]
Metabolic inflammation may be an important risk factorCausality is quite possible, via IGF, VEGF
Various type of immune, inflammatory cells are present in cancer lociThey can be innocent bystanders
Immune cells affect malignant cells through cytokines, chemokines, growth factors, prostaglandins, and reactive oxygen and nitrogen speciesThis fact proves that there is an interaction between immune cells and cancer cells but causal relationship is yet to be established
Inflammation is present from tumor initiation to metastasisIt does not mean inflammation causes cancer. Inflammation may be a part of disease processes in cancer
NF-κB signaling pathway can be two-way street: NF-κB from immune system can suppress cancer progress; also NF-κB from cancer cells to resist immune actionNF-κB is universal biologic transcription factor and difficult to prove its involvement as a causal factor in carcinogenesis
Certain immune/inflammatory actions are dispensable in some stages and indispensable in others